Integrity of Scientific Data: Transparency of Clinical Trial Data

Area of Science:

• Clinical research ethics
• Scientific integrity
• Data management

Background:

• The scientific method relies heavily on the integrity of clinical trial data.
• Instances of scientific fraud are recurrent and undermine trust in research.
• Institutional systems require robust mechanisms for addressing data integrity issues.

Purpose of the Study:

• To define and characterize scientific fraud in clinical research.
• To explore methods for recognizing and preventing fraud, particularly within institutional research.
• To address the challenges in identifying and managing fraudulent activities in studies.

Main Methods:

• A roundtable discussion was convened to define fraud and its implications.
• Exploration of ethical considerations and procedural adherence in clinical trials.
• Consideration of statistical methods for detecting anomalous data patterns indicative of fraud.
• Discussion on the protection of whistleblowers and the implementation of fraud detection procedures.

Main Results:

• Fraud in research involves intentional deception, ranging from incompetence to data fabrication.
• Frequency of fraud is difficult to ascertain but may affect up to 1% of studies.
• Ethical breaches and procedural non-compliance are common facets of research fraud.
• Good Clinical Practices (GCP) are inconsistently applied, especially by institutional sponsors.

Conclusions:

• Clear procedures for fraud detection and management are needed, particularly for institutional clinical trials.
• Statistical techniques can aid in identifying potential data manipulation.
• Protecting whistleblowers is essential for uncovering fraudulent research.
• Standardized protocols for addressing identified fraud are currently lacking but recommended.